Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FBCRT
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
LN488-01-2
|
|||||
| Synonyms |
LN488-01-2
Click to Show/Hide
|
|||||
| Organization |
LEVENA (SUZHOU) BIOPHARMA CO., LTD.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.2
|
|||||
| Structure |
|
|||||
| Antibody Name |
BY016
|
Antibody Info | ||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
Antigen Info | ||||
| Payload Name |
DX-8951 derivative (DXd)
|
Payload Info | ||||
| Payload Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Mc-Gly-Gly-Phe-Gly
|
Linker Info | ||||
| Conjugate Type |
Cysteine-maleimide conjugation
|
|||||
| Combination Type |
Deruxtecan
|
|||||